Dermatology relies heavily on imaging, and integrating various imaging types is a top priority. As #SIIM comes to a close, we're highlighting the discussion our President Morris Panner had with Dr. Veronica Rotemberg from Memorial Sloan Kettering Cancer Center. Tune in as they discuss how imaging enables healthcare providers to deliver better patient care in dermatology. #MinutesWithMorris
Intelerad’s Post
More Relevant Posts
-
Comprehension in dermatology is realized through visual communication. Without it there is chaos. Battles for our patients will continue if we only put out fires created by delayed diagnosis. The WAR ON SKIN CANCER will be won when we prioritize preventative medicine. This begins with dermoscopy. #skincancer #melanoma #digitalhealth #artificialintelligence #ai
To view or add a comment, sign in
-
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment : In this Dermatology Times article, listen to Christopher Bunick, MD, PhD, as he delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis. https://lnkd.in/gsDAMw86
To view or add a comment, sign in
-
Rocco Serrao, MD, found his expertise in inflammation, particularly #psoriasis. He delved into the promising data on #bimekizumab at Maui Dermatology NP+PA Fall 2023, shedding light on its potential to block key signaling pathways and achieve impressive PASI scores in phase 3 trials. #DermatologyInnovation #PsoriasisSolutions 🌟🔬 https://lnkd.in/gX3ygCXx
Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval
dermatologytimes.com
To view or add a comment, sign in
-
At the end of #AAD2024, Andrew Alexis, MD, MPH, vice-chair for diversity and inclusion for the department of dermatology and professor of clinical dermatology at Weill Cornell Medicine, discussed the significance of new tapinarof cream findings as they relate to the current state of clinical management of atopic dermatitis skin of color. Alexis additionally talked about what specific clinical and demographic challenges patients of color face in adequately treating chronic skin diseases, and what further steps may his peers take to further improve representation in research and care tailored to skin of color. Read here: https://lnkd.in/e_uCYy4M
To view or add a comment, sign in
-
-
Experts in dermatology provide a comprehensive year in review regarding the management of plaque psoriasis, highlighting key therapeutic approvals from 2023. The discussion will highlight pivotal clinical studies supporting these approvals and our discussion will then pivot to have a special focus on addressing the unique challenges faced by treating patients with skin of color and treatment access barriers. Explore the series here: https://ow.ly/az7y50RSCnx
To view or add a comment, sign in
-
-
New Publication in Dermatology and Therapy: The analysis of an IL-13 inhibitor across EASI body regions and clinical signs of Atopic Dermatitis, results from ADvocate 1 & ADvocate 2 trials. View the full publication here: https://e.lilly/4ayAaKR
To view or add a comment, sign in
-
Want to learn more about our AtopicDermatitis registry. Let’s schedule a meeting and discuss how we can support your dermatology development initiatives. #rwe #rwd #registry #atopicdermatitis
Now available online American Academy of Dermatology #JAAD: our co-authored research paper. It describes the demographic, clinical, and treatment characteristics among CorEvitas #AtopicDermatitis (AD) Registry patients in the first 2.5 years after inception and stratified by current systemic therapy use. https://hubs.la/Q02rbhvB0 #RWE #RWD #diseaseregistry
To view or add a comment, sign in
-
-
Journal of Dermatology for NPs & PAs co-founder and editor Douglas DiRuggiero, DMSc, MHS, PA-C, talks to Raj Chovatiya, MD, PhD, MSCI, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, about how and why to encourage non-segmental #vitiligo patients to stick with daily application of ruxolitinib cream 1.5% (Opzelura, Incyte). They also discuss how this cream repigments multiple body parts in vitiligo and share tips on the best ways to address patient safety concerns. https://lnkd.in/dqhr7RW9
To view or add a comment, sign in
-
-
New article via Dermatology Times: Researchers examined the effect of the DecisionDx-Melanoma 31-gene expression profile (31-GEP) test on survival outcomes. Findings showed that patients with 31-GEP testing had a 29% lower melanoma-specific survival mortality and a 17% lower overall mortality than patients who did not have the test. Full article: https://hubs.la/Q01_wp6z0 #DecisionDx #Melanoma #GEP
To view or add a comment, sign in
-
-
A strong upward trend of digital health interventions (DHI) has been identified in the recent years📈 with skin cancer identification being the most common DHI target. According to Reinders et al, “Improvements can be achieved by data-supported decision-making in diagnosis and treatment, enhanced communication between individuals involved in the process of care, improved self-management by patients with long-term conditions.” Overall, it is said that digital health interventions may improve efficacy and efficiency of care in dermatology. You can read the full article here: https://bit.ly/3OUwlqp
To view or add a comment, sign in
-